Epiktet has completed the acquisition of Amelis, expanding its reach into the home care sector to meet growing societal demands for such services.

Deal-at-a-Glance
AcquirerEpiktet (France)
TargetAmelis (France)
ValueUndisclosed
TypeAcquisition
Closed Date2024-06-24
Announced Date2024-06-24
Buy-side AdvisorsRAISE Invest, GENEO Capital Entrepreneur
Sell-side AdvisorsThe Halifax Group
Legal Buy-SideNot Disclosed
Legal Sell-SideNot Disclosed

The acquisition aims to capitalize on Epiktet’s existing service provision expertise and enhance its portfolio with Amelis’ home care offerings, which cater to the aging population's need for personalized in-home support.

Deal Mechanics

Epiktet secured financial backing from RAISE Invest and GENEO Capital Entrepreneur as it looked to expand into a new market segment. The Halifax Group acted on behalf of Amelis, facilitating what is seen as a strategic entry point for Epiktet into the home care sector.

Strategic Rationale

Epiktet’s move into home care reflects a broader trend among service providers looking to address an aging demographic and rising demand for at-home health services. Amelis, previously a subsidiary of Sodexo Home Care, is well-positioned with its established client base and operational infrastructure.

Financial Context

Details regarding the financial terms of the acquisition have not been disclosed. However, analysts view this as a significant step for Epiktet to diversify its service offerings and strengthen its position in the professional services sector.